DBOCX
Price
$21.83
Change
-$0.07 (-0.32%)
Updated
Apr 17 closing price
Net Assets
258.17M
RLBEX
Price
$32.90
Change
-$0.08 (-0.24%)
Updated
Apr 17 closing price
Net Assets
225.48B
Ad is loading...

DBOCX vs RLBEX

Header iconDBOCX vs RLBEX Comparison
Open Charts DBOCX vs RLBEXBanner chart's image
BNY Mellon Balanced Opportunity C
Price$21.83
Change-$0.07 (-0.32%)
VolumeN/A
Net Assets258.17M
American Funds American Balanced R4
Price$32.90
Change-$0.08 (-0.24%)
VolumeN/A
Net Assets225.48B
DBOCX vs RLBEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DBOCX vs. RLBEX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBOCX is a Buy and RLBEX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 225B vs. DBOCX (258M). RLBEX pays higher dividends than DBOCX: RLBEX (1.97) vs DBOCX (0.44). DBOCX was incepted earlier than RLBEX: DBOCX (21 years) vs RLBEX (23 years). DBOCX (2.06) is less costly to investors than RLBEX (0.60). RLBEX is a more actively managed with annual turnover of: 171.00 vs. DBOCX (46.25). RLBEX has a lower initial minimum investment than DBOCX: RLBEX (250) vs DBOCX (1000). RLBEX annual gain was more profitable for investors over the last year : 2.55 vs. DBOCX (-2.29). RLBEX return over 5 years is better than : 31.66 vs. DBOCX (7.15).
DBOCXRLBEXDBOCX / RLBEX
Total Expense Ratio1.900.60317%
Annual Report Gross Expense Ratio2.060.60343%
Fund Existence21 years23 years-
Gain YTD-6.290-3.702170%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets258M225B0%
Annual Yield % from dividends0.441.9723%
Returns for 1 year-2.292.55-90%
Returns for 3 years-3.729.93-37%
Returns for 5 years7.1531.6623%
Returns for 10 years2.8346.296%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FANUY12.050.38
+3.26%
Fanuc Corporation
ELTP0.42N/A
+0.24%
Elite Pharmaceuticals, Inc.
HYSNY3.27N/A
N/A
Hysan Development Co., Ltd.
AAIGF6.88-0.01
-0.09%
AIA Group, Ltd.
SOUHY8.52-0.07
-0.81%
South32 Ltd.